A Neurotrophic Model for Stress-Related Mood Disorders

Biological Psychiatry

Volumn 59, Issue 12, 2006, Pages 1116-1127

  Duman, Ronald S ^a   Monteggia, Lisa M ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antidepressant; BDNF; behavior; depression; neurogenesis; VEGF

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; MAPROTILINE; MEMANTINE; MIANSERIN; MONOAMINE OXIDASE INHIBITOR; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIANEPTINE; TRANYLCYPROMINE; VASCULOTROPIN; VENLAFAXINE;

ADRENAL GLAND; AUTOPSY; BRAIN ATROPHY; BRAIN CORTEX; DEPRESSION; DNA POLYMORPHISM; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; FORCED SWIMMING TEST; HIPPOCAMPUS; HUMAN; MOOD DISORDER; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NEUROTROPISM; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; STRESS; TASK PERFORMANCE;

ADULT; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; MODELS, NEUROLOGICAL; MOOD DISORDERS; RATS; STRESS, PSYCHOLOGICAL;

EID: 33745208951     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.02.013     Document Type: Review

References (134)

1. Aberg M., Aberg N.D., Hedbacker H., Oscarsson J., and Eriksson P.S. Peripheral infusion of IGF-1 selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20 (2000) 2896-2903
2. Adlard P., Perreau V.M., Engesser-Cesar C., and Cotman C.W. The timecourse of induction of brain-derived neurotrophic factor nRNA and protein in the rat hippocampus following voluntary exercise. Neurosci Lett 363 (2004) 43-48
3. Altar C., Laeng P., Jurata L.W., Brockman J.A., Lemire A., Bullard J., et al. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 24 (2004) 2667-2677
4. Altar C., Whitehead R.E., Chen R., Wortwein G., and Madsen T.M. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54 (2003) 703-709
5. Anderson M., Aberg M.A., Nilsson M., and Eriksson P.S. Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res Dev Brain Res 134 (2002) 115-122
6. Aydemir O., Deveci A., and Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients. A preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29 (2004) 261-265
7. Barbany G., and Persson H. Regulation of neurotrophin mRNA expression in the rat brain by glucocorticoids. Eur J Neurosci 4 (1992) 396-403
8. Barrientos R., Sprunger D.B., Campeau S., Higgins E.A., Watkins L.R., Rudy J.W., et al. Brain-derived neurotrophic factor mRNA downregulation induced by social isolation is blocked by intrahippocampal interleukin-1 receptor anatagonist. Neuroscience 121 (2003) 847-853
9. Benraiss A., Chmielnicki E., Lerner K., Roh D., and Goldman S.A. Adenoviral brain-derived neurotropohic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J Neurosci 21 (2001) 6718-6731
10. Bodnoff S., Suranyi-Cadotte B., Aitken D.H., Quirion R., and Meaney M.J. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl) 95 (1988) 298-302
11. Bremner J.D., Randall P., Scott T.M., Bronen R.A., Seibyl J.P., Southwick S.M., et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 152 (1995) 973-981
12. Brown J., Cooper-Kuhn C.M., Kempermann G., Van Praag H., Winkler J., Gage F.H., et al. Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci 17 (2003) 2042-2046
13. Cao L., Jiao X., Zuzga D.S., Liu Y., Fong D.M., Young D., et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 36 (2004) 827-835
14. Castren E. Is mood chemistry?. Nat Rev Neurosci 6 (2005) 241-246
15. Chao H., Sakai R.R., Ma L.Y., and McEwen B.S. Adrenal steroid regulation of neurotrophic factor expression in the rat hippocampus. Endocrinology 139 (1998) 3112-3118
16. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.-F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50 (2001) 260-265
17. Chourbaji S., Hellweg R., Brandis D., Zorner B., Zacher C., Lang U.E., et al. Mice with reduced bran-derived neurotrophic factor expression show decreased choline acetyltransferade activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res 121 (2004) 28-36
18. Conti A., Cryan J.F., Dalvi A., Lucki L., and Blendy J.A. CREB is essential for the upregulation of BDNF transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22 (2002) 3262-3268
19. Coppell A., Pei Q., and Zetterstron T.S.C. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44 (2003) 903-910
20. Cotter D., Mackay D., Landau S., Kerwin R., and Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58 (2001) 545-553
21. Cryan J., Markou A., and Lucki I. Assessing antidepressant activity in rodents. Recent developments and future needs. Trends Pharmacol Sci 23 (2002) 238-245
22. Cryan J.F., Dalvi A., Jin S.H., Hirsch B.R., Lucki I., and Thomas S.A. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther 298 (2001) 651-657
23. Dalvi A., and Lucki I. Murine models of depression. Psychopharmacology (Berl) 147 (1999) 14-16
24. De Foubert G., Carney S.L., Robinson C.S., Destexhe E.J., Tomlinson R., Hicks C.A., et al. Fluoxetiine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128 (2004) 597-604
25. Dias B., Banerjee S.B., Duman R.S., and Vaidya V.A. Differentiation regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45 (2003) 553-563
26. Dow A., Russell D.S., and Duman R.S. Regulation of activin mRNA and smad2 phosphorylation by antdepressant treatment in the rat brain. Effects in behavioral models. J Neurosci 25 (2005) 4908-4916
27. Dranovsky A., and Hen R. Hippocampal neurogenesis. Regulation by stress and antidepressants. Biol Psych 59 (2006) 1136-1143
28. Duman R. Depression. A case of neuronal life and death?. Biol Psychiatry 56 (2004) 140-145
29. Duman R. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 5 (2004) 11-25
30. Duman R., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 54 (1997) 597-606
31. Dwivedi Y., Rao J.S., Hooriyah S.R., Kotowski J., Conley R.R., Roberts R.C., et al. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry 60 (2003) 273-282
32. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., and Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77 (2001) 916-928
33. Egan M., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
34. Eisch A., Bolanos C.A., de Wit J., Simonak R.D., Pudiak C.M., Barrot M., et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway. A role in depression. Biol Psychiatry 54 (2003) 995-1005
35. Ernfors P., Lee K.-F., and Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368 (1994) 147-150
36. Evans S., Choudary P.V., Neal C.R., Li J.Z., Vawter M.P., Tomita H., et al. Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A 101 (2004) 15506-15511
37. Fabel K., Fabel K., Tam B., Kaufer D., Baiker A., Simmons N., et al. VEGF is necessary for exercise-induced adult hippocampal neurogenesis. Eur J Neurosci 18 (2003) 2803-2812
38. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
39. Gage F. Mammalian neural stem cells. Science 287 (2000) 1433-1438
40. Garza A., Ha T.G., Chen M.J., and Russo-Neustadt A.A. Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain. Pharmacol Biochem Behav 77 (2004) 209-220
41. Geller B., Badner J.A., Tillman R., Christian S.L., Bolhofner K., and Cook E.H. Linkage disequilibrium in the brain-derived neurotrophic fctor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 161 (2004) 1698-1700
42. Gervasoni N., Aubrey J.M., Bondolfi G., Osiek G., Schwald M., Bertschv G., et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51 (2005) 234-238
43. Gold P., and Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression. High vs low CRH/NE states. Mol Psychiatry 7 (2002) 254-275
44. Gonul A., Akdeniz F., Taneli F., Donat O., Eker C., and Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255 6 (2005) 381-386
45. Gorski J., Zeiler S.R., Tamowski S., and Jones K.R. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 23 (2003) 6856-6865
46. Gould E., Panapat P., Rydel T., and Hastings N. Regulation of hippocampal neurogenesis in adulthood. Biol Psychiatry 48 (2000) 715-720
47. Gurvits T., Shenton M.E., Hokama H., Ohta H., Lasko N.B., Gilbertson M.W., et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 40 (1996) 1091-1099
48. Heine V., Zareno J., Maslam S., Joels M., and Lucassen P.J. Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. Eur J Neurosci 21 (2005) 1304-1314
49. Holmes A., Murphy D.L., and Crawley J.N. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 161 (2002) 160-167
50. Holoubek G., Noldner M., Treiber K., and Muller W.E. Effect of chronic antidepressant treatment in beta-receptor coupled signal transduction cascade. Which effect matters most?. Pharmacopsychiatry 37 suppl 2 (2004) S113-S119
51. Hong C., Huo S.J., Yen F.C., Tung C.L., Pan G.M., and Tsai S.J. Association study of a brain-derived neurotrophic factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48 (2003) 186-189
52. Hoshaw B., Malberg J.E., and Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res 1037 (2005) 204-208
53. Jiang X., Xu K., Hoberman J., Tian F., Marko A.J., Waheed J.F., et al. BDNF variation and mood disorders. A novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30 7 (2005) 1353-1361
54. Jin K., Zhu Y., Yunjuan S., Mao X.O., Xie L., and Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenisis in vitro and in vivo. Proc Natl Acad Sci U S A 99 (2002) 11946-11950
55. Karege F., Perret H., Bondolfi G., Schwald M., Bertschv G., and Aubrey J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychol Res 109 (2002) 143-148
56. Karege F., Vaudan G., Schwald M., Perroud N., and La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 136 (2005) 29-37
57. Khawaja X., Xu J., Liang J.-J., and Barrett J.E. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment. Impliations for depressive disorders and future therapies. J Neurosci 75 (2004) 451-460
58. Kuroda Y., and McEwen B.S. Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus. Brain Res Mol Brain Res 59 (1998) 35-39
59. Lauterborn J., Truong G.S., Baudry M., Bi X., Lynch G., and Gall C.M. Chronic elevation of brain-derived neurotrophic factor by ampakines. J Pharmacol Exp Ther 307 (2003) 297-305
60. Lee J., Duan W., and Mattson M.P. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 82 (2002) 1367-1375
61. Lucassen P., Muller M.B., Holsboerr F., Bauer J., Holtrop A., Wouda J., et al. Hippocampal apoptosis in major depression is a minor event and absent from sub-areas at risk for glucocorticoid overexposure. Am J Pathol 158 (2001) 453-468
62. MacQueen G., Ramakrishnan K., Croll S.D., Siuciak J.A., Yu G., Young L.T., et al. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 5 (2001) 1145-1153
63. Madsen T.M., Treschow A., Bengzon J., Bolwig T.G., Lindrall O., and Tingstrom A. Increased neurogenesis in a model of electro convulsive therapy. Biol Psychiatry 47 (2000) 1043-1049
64. Malberg J., and Duman R.S. Cell proliferation in adult hippocmpus is decreased by inescapable stress. Reversal by fluoxetine treatment. Neuropsychopharmacology 28 (2003) 1562-1571
65. Malberg J., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult hippocampus. J Neurosci 20 (2000) 9104-9110
66. Mallei A., Shi B., and Mocchetti I. Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons. Mol Pharmacol 61 (2002) 1017-1024
67. Marvanova M., Lakso M., Pirhonen J., Nawa H., Wong G., and Castren E. The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci 18 (2001) 247-258
68. Mayorga A.J., Dalvi A., Page M.E., Zimov-Levinson S., Hen R., and Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J Pharmacol Exp Ther 298 (2001) 1101-1107
69. McEwen B. Stress and hippocampal plasticity. Curr Opin Neurobiol 5 (1999) 205-216
70. McEwen B. Effects of adverse experiences for brain structure and function. Biol Psychiatry 48 (2000) 721-731
71. Miro X., Perez-Torres S., Puigdomenech P., Palacios J.M., and Mengod G. Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization. Synapse 45 (2002) 259-269
72. Mombereau C., Kaupmann K., Froestl W., Sansig G., van der Putten H., and Cryan J.F. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 29 (2004) 1050-1062
73. Monteggia L., Barrot M., Powell C.M., Berton O., Galanis V., Gemelli T., et al. Essential role of brain-derived neuroprophic factor in adult hippocampal function. Proc Natl Acad Sci U S A 101 (2004) 10827-10832
74. Muller M., Lucassen P.J., Yassouridis A., Hoogendijk J.G., Holsboer F., and Swabb D.F. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 14 (2001) 1603-1612
75. Muller M., Tosci N., Kresse A.E., Poat A., and Keck M.E. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology 23 (2000) 205-215
76. Nakata K., Ujike H., Sakai A., Uchida N., Nomura A., and Imamura T. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 337 (2003) 17-20
77. Neeper S., Gomez-Pinilla F., Choi J., and Cotman C.W. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 726 (1996) 49-56
78. Nestler E., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
79. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., and Kennedy J.L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder. Evidence from a family-based association study. Am J Hum Genet 71 (2002) 651-655
80. Newton S., Collier E., Hunsberger J., Adams D., Salvanayagam E., and Duman R.S. Gene profile of electroconvulsive seizures. Induction of neurogenic and angiogenic factors. J Neurosci 23 (2003) 10841-10851
81. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15 (1995) 7539-7547
82. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16 (1996) 2365-2372
83. Nibuya M., Takahashi M., Russel D.S., and Duman R.S. Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett 267 (1999) 81-84
84. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 95 (1998) 13290-13295
85. Palmer T., Willhoite A.R., and Gage F.H. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425 (2000) 479-494
86. Pan W., Banks W.A., Fasold M.B., Bluth J., and Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37 (1998) 1553-1561
87. Pencea V., Bingaman K.D., Wiegand S.J., and Luskin M.B. Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, sseptum, thalamus, and hypothalamus. J Neurosci 21 (2001) 6706-6717
88. Pizarro J., Lumley L.A., Medina W., Robinson C.L., Shah J.D., Mark B., et al. Acute social defeat reduces neurotrophin expression in brain cortical and susbcortical areas in mice. Brain Res 1025 (2004) 10-20
89. Porsolt R., Le Pichon M., and Jalfre M. Depression. A new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
90. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45 (1999) 1085-1098
91. Rasmussen A., Shi L., and Duman R.S. Down-regulation of BDNF mRNA in the hippocampal dentate gyrus after re-axposure to cues previously associated with footshock. Neuropsychopharmacology 27 (2002) 133-142
92. Ren-Patterson R.F., Cochran L.W., Holmes A., Sherrill S., Huang S.J., Tolliver T., et al. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res 79 (2005) 756-771
93. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., et al. Conditioned deletion of brain-derived neurotrophic factor in the post-natal brain leads to obesity and hyperactivity. Mol Endocrinol 15 (2001) 1748-1757
94. Roceri M., Cirulli F., Pessina C., Peretto P., Racagni G., and Riva M.A. Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions. Biol Psychiatry 55 (2004) 708-714
95. Roceri M., Hendriks W., Racagni G., Elenbroek B.A., and Riva M.A. Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Mol Psychiatry 7 (2002) 609-616
96. Russo-Neustadt A., Alejandre H., Garcia C., Ivy A.S., and Chen M.J. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 29 (2004) 2189-2199
97. Russo-Neustadt A., Beard R.C., and Cotman C.W. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21 (1999) 679-682
98. Russo-Neustadt A., Beard R.C., Huang Y.M., and Cotman C.W. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 101 (2000) 305-312
99. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., et al. Activation of the trkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23 (2003) 349-357
100. Sairanen M., Lucas G., Ernfors P., Castren M., and Casren E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci 25 (2005) 1089-1094
101. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenisis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
102. Sapolsky R. Glucocorticoids and atrophy of the human hippocampus. Science 273 (1996) 749-750
103. Sapolsky R. Depression, antidepressants, and the shrinking hippocampus. Proc Natl Acad Sci U S A 98 (2001) 12320-12322
104. Schaaf M., de Jong J., de Kloet E.R., and Vreugdenhil E. Downregulation of BDNF mRNA and protein in the rat hippocamppus by corticosterone. Brain Res 813 (1998) 112-120
105. Schanzer A., Wachs F.P., Wilhelm D., Acker T., Copoer-Kuhn C., Beck H., et al. Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol 14 (2004) 237-248
106. Schramm N.L., McDonald M.P., and Limbird L.E. The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci 21 (2001) 4875-4882
107. Shanks N., and Anisman H. Strain-specific effects of antidepressants on escape deficits induced by inescapable shock. Psychopharmacology (Berl) 99 (1989) 122-128
108. Sheline Y., Gado M.H., and Kraemer H.C. Untreated depression and hippocampal volume loss. Am J Psychiatry 160 (2003) 1-3
109. Sherman A., Allers G.L., Petty J., and Henn F.A. A neuropharmacologically-relevant animal model of depression. Neuropharmacology 18 (1979) 891-893
110. Shimizu E., Hashimoto K., Olamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54 (2003) 70-75
111. Shirayama Y., Chen A.C.-H., Nakagawa S., Russell R.S., and Duman R.S. Brain derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22 (2002) 3251-3261
112. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R. Antidepressant-like effect of brain derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56 (1997) 131-137
113. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lin Y.-M., Tsan G., et al. Family-based association study of 76 candidate genes in bipolar disorder. BDNF is a potential risk locus. Mol Psychiatry 7 (2002) 579-593
114. Smith M., Zhang L.-X., Lyons W.E., and Mamounas L.A. Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. Neuroreport 8 (1997) 1829-1834
115. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress alters the express of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15 (1995) 1768-1777
116. Soppet D., Escandon E., Maragos J., Middlemas D.S., Reid S.W., Blair J., et al. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell 65 (1991) 895-903
117. Squinto S.P., Stitt T.N., Aldrich T.H., Davis S., Bianco S.M., Radziejewski C., et al. TrkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65 (1991) 885-893
118. Stockmeier C., Mahajan G.J., Konick L.C., Overholser J.C., Jurjus G.J., Meltzer H.Y., et al. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 56 (2004) 640-650
119. Strauss J., Barr C.L., George C.J., King N., Shaikh S., Devlin B., et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am J Med Genet B Neuropsychiatr Genet 131 (2004) 16-19
120. Svenningsson P., Tzavara E.T., Liu F., Fienberg A.A., Nomikos G.G., and Greengard P. DARPP-32 mediates serotonergic neurotransmission in the forebrain. Proc Natl Acad Sci U S A 99 (2002) 3188-3193
121. Thiébot M.-H., Martin P., and Puech A.J. Animal behavioural studies in the evaluation of antidepressant drugs. Br J Psychiatry 160 (1992) 44-50
122. Thierry B., Steru L., Simon P., and Porsolt R.D. The tail suspension test. Ethical considerations. Psychopharmacology (Berl) 90 (1986) 284-285
123. Trejo J., Carro E., and Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 21 (2001) 1628-1634
124. Ueyama T., Kawai Y., Nemoto K., Sekimoto M., Tone S., and Senba E. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 28 (1997) 103-110
125. Vaidya V., Marek G.J., Aghajanian G.A., and Duman R.S. 5-HT2A receptor-mediated regulation of BDNF mRNA in the hippocampus and the neocortex. J Neurosci 17 (1997) 2785-2795
126. Van Hoomissen J.D., Chambliss H.O., Holmes P.V., and Dishman R.K. Effects of chronic exercise and imipramine on mRNA for BDNF after olfactory bulbectomy in rat. Brain Res 974 (2003) 228-235
127. Vermetten E., Vythilingam M., Southwick S.M., Charney D.S., and Bremner J.D. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol Psychiatry 54 (2003) 693-702
128. Vinet J., Cara S., Blom J.M., Brunello N., Barden N., and Tascedda F. Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuropharmacology 47 (2004) 1062-1069
129. Vollmayr B., Simonis C., Weber S., Gass P., and Henn F. Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol Psychiatry 54 (2003) 1035-1040
130. Wagner J., Black I.B., and DiCicco-Bloom E. Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor. J Neurosci 19 (1999) 6006-6016
131. Willner P. Animal models of depression. An overview. Pharmacol Ther 45 (1990) 425-455
132. Xu B., Goulding E.H., Zang K., Cepoi D., Cone R.D., Jones K.R., et al. Brain-derived neurotropohic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6 (2003) 736-742
133. Xu Y.-L., Reinscheid R.K., Hitron-Resendiz S., Clark S.D., Wang Z., Lin S.H., et al. Neuropeptide S. A neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43 (2004) 487-497
134. Zorner B., Wolfer D.P., Brandis D., Kretz O., Zacher C., Madani R., et al. Forebrain-specific trkB-receptor knockout mice. Behaviorally more hyperactive than "depressive.". Biol Psychiatry 54 (2003) 972-982